Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

ScienceDaily
Jul 6, 2019, 12:34 pm1.3k ptsInterestingTop
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardizing efficacy.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

U.S. Will Not Extend USMCA 130

World Cup fans are more likely to choose sustainable products and brands 130

Southeast Asian nations chart important new course toward environmental justice (commentary) 127

This unfathomably huge fungal network keeps Earth cool and green 121

17,000 New EV Chargers Coming To The UK 121

Record heat pushes human-driven warming to 1.39C, 1.5C could arrive by 2030 119

Even weak ocean models can provide valuable information for environmental forecasts, study shows 117

New global tracker maps urban growth in hazard zones every six months 114

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.